By: Landon Grace
The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care
A public health crisis is brewing in plain sight, with vision-threatening eye disease increasing at a pace our healthcare system is not prepared to manage. America’s population is aging rapidly, and age is one of the strongest risk factors for vision loss. By 2030, every baby boomer will be at least 65 years of age, which will significantly expand the nation’s older population. Most concerning, the 85+ age group is projected to more than double, rising from 6.7 million in 2020 to 14.4 million in 2040. This demographic shift will bring many healthcare challenges, and eyesight loss for millions is among the most urgent.
The Centers for Disease Control and Prevention (CDC) projects a devastating increase in vision-threatening diseases by 2050, with annual costs reaching $373 billion—a staggering 157% increase from previous decades. Much of this burden stems from three major eye diseases, which all increase in prevalence and severity with age. Age-related macular degeneration (AMD) is expected to nearly double by the end of the decade, glaucoma cases will almost double by 2030, and diabetic retinopathy – already the most common vision-threatening disease – currently affects 7.7 million Americans and is projected to reach 11.3 million.
The impact on patients goes far beyond loss of eyesight. Visual impairment reduces patient quality of life more severely than cardiovascular disease, diabetes, or cancer. It can also increase the risks of secondary diseases, hearing loss, depression, falls, nursing home admissions, caretaker strain, and social isolation. The financial toll of vision loss is equally profound: people who experience blindness face nearly double the healthcare costs of those without vision loss.
Source: MedCity News